Immunotherapy helps HIV-infected people with cancer treatment
-
Last Update: 2020-06-09
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Fred Hutch immunotherapy researcher DrMac Cheever is director of the Cancer Immunotherapy Pilot Organization and senior author of the JAMA Oncology paperThe study was conducted at seven different cancer centers in the United States, including the National Cancer Institute in Bethesda, Marylandoverall, pembrolizumab is similar in HIV and cancer patients to clinical trials in the general populationWhile the main purpose of the study is to assess safety, it also provides information about the drug's anti-cancer activity in these patientsA lung cancer patient has a complete response to treatment and has also been observed in important HIV-related cancers, including non-Hodgkin's lymphoma, Caposi sarcoma and liver cancersource: Immunotherapy drug found in the cure cancer patient s with HIV, study suggestsoriginal source: Thomas SUldrick, Priscilla HGon?alves, Maher Abdul-Hay, Alisa JClaeys, Brinda Emu, Marc SErnstoff, Steven PFlynn, Lawrence Fong, Judith CKaiser, Andre MLacroix, Steve YLee, AndreRamaswami, Elad Sharon, Mario Sznol, Chia-Ching (Jackie) Wang, Robert Yarchoan, Martin ACheeverAssessment of safety y safety of Pembrolizumab in Patients with HIV and Advanced Cancer-A Phase 1 Study.JAMAy, 2019; DOI: 10.1001/jamaoncol.2019.2244
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
